Lakefront Biotherapeutics (GLPGF) Invested Capital (2020)

Lakefront Biotherapeutics (GLPGF) has reported Invested Capital for 1 consecutive years, with $3.2 billion the latest figure, recorded in Q4 2020.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $3.2 billion in Q4 2020; TTM through Dec 2020 was $3.2 billion, a N/A change from a year earlier, with the FY2020 full-year figure at $3.2 billion, changed N/A from the prior year.
• Invested Capital was $3.2 billion for Q4 2020 at Lakefront Biotherapeutics.
• Over five years, Invested Capital peaked at $3.2 billion in Q4 2020 and troughed at $3.2 billion in Q4 2020.